Eisai unveils digital platform for kidney cancer patients Eisai has launched a 'digital destination', called Kompass, that aims to support patients after they have been given a diagnosis of kidney cancer.

#Eisai #digitalplatform #kidneycancerpatients #kidneycancer #digitaldestination #Kompass #kidneycancerdiagnosis #KidneyCancerKompass #patientorganisations #KCCure #KidneyCAN #KidneyCancerAssociation #NationalKidneyFoundation #Lenvima #lenvatinib #MSD #renalcellcarcinoma #RCC
zurl.co/qpSNo

#MSD and #Eisai's combination of #Keytruda and #Lenvima has become a driver of growth for both products, but their efforts to extend the regimen into #livercancer have hit a hurdle. #kidneycancer

buff.ly/wwre849

Notes on cancer medications and the ridiculous tariffs.
#Cancer #tRumpTariffs #CancerMedication #Lenvima #MedicalCosts #tariffs

Eisai Showcases Key Cancer Research Innovations at ASCO 2025 Eisai is proud to present its cutting-edge oncology research at the ASCO 2025 Annual Meeting, highlighting key studies in liver and endometrial cancer treatments.

Eisai Showcases Key Cancer Research Innovations at ASCO 2025 #United_States #Chicago #oncology #Eisai #LENVIMA

@AASLDtweets clearly the era of combo systemic Rx for #HCC has been ushered with #tecentriq + #avastin , #keytruda + #lenvima and now #Opdivo +#yervoy looming at the horizon. I definitely foresee an HCC centric #livermtg20 #LiverMtg19

@EASLedu @EASLnews Dr. Reig @BCLC_group gives a great review of approved and upcoming #HCC systemic therapies including #nexavar #lenvima #cabometyx #stivarga #opdivo #keytruda #cyramza #ILC2018